FDA Raids Maker of ‘Poppers’ Inhalant Drug, Company Says
9 Articles
9 Articles
FDA Raids Maker of ‘Poppers’ Inhalant Drug, Company Says
The U.S. Food and Drug Administration (FDA) has cracked down on at least one manufacturer of a type of inhalant drug known as “poppers,” according to a recent statement by that manufacturer. Double Scorpio, a Texas-based manufacturer of the inhalant, said in a statement on its website last week that it has “stopped all operations following a search and seizure” at its offices by the FDA. “We don’t have a lot of information to share, but we belie…
FDA Raids Poppers Manufacturer.
The U.S. Food and Drug Administration (FDA) has reportedly taken action against an Austin-based company involved in the production of “poppers,” a popular inhalant drug linked with clubbing and homosexual activities. Double Scorpio, the company in question, stated on its website that it ceased operations after the FDA executed a search and seizure at its offices. This follows Robert F. Kennedy Jr.’s recent appointment as head of the U.S. Departm…
U.S Crackdown on Poppers: Major Producer Shuts Down Amid Anti-LGBTQ+ Policies
The FDA has initiated a crackdown on poppers, resulting in major brands shutting down. As the agency enforces stricter regulations under RFK Jr.’s leadership, questions arise about the future of poppers and their impact on LGBTQ+ nightlife.
US FDA Targets Injectable CBD Firm
A company promoting an intravenous form of cannabidiol (CBD) has been sent a warning letter from the U.S. Food and Drug Administration. Cannabidiol is a non-intoxicating cannabinoid that is most commonly available in oral forms for ingestion. According to the FDA, firm in question is marketing an intravenously administered CBD product as a dietary supplement […] The post US FDA Targets Injectable CBD Firm appeared first on Hemp Gazette.
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium



